24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Ichilov Medical Center
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:33
Full list of Israeli startup M&As in 2025
17:24
Fortinet acquires Israeli cyber startup Suridata for tens of millions to boost SaaS protection
17:03
Full list of Israeli high-tech funding rounds in 2025
16:59
Rhino Federated Computing raises $15M Series A to power AI without sharing data
More stories
Buzz
Most popular
Daily
Weekly
1
Intel considering selling off networking business in strategic overhaul
2
Gigi Levy-Weiss and Redis co-founder Yiftach Shoolman launch defense tech startup Line 5, raising $20M Seed round
3
“Execution, execution, execution”: Intel CEO vows to rebuild through results
4
The 50 most promising Israeli startups - 2025
5
Cyber startup Cyera raising hundreds of millions at over $6 billion valuation
More news
Ichilov Medical Center
2 stories about Ichilov Medical Center
"The genome project will change the face of medicine in Israel and save human lives"
10.11.24
|
Roni Dori
Psifas is an ambitious new genome project aiming to create a genetic database of Israel’s citizens, with a budget of NIS 250 million. The collected information already provides information that will make it possible to treat life-threatening diseases in the subjects. The hope is that after accumulating 100,000 samples, the database will help jumpstart the biotech industry. CEO Prof. Gabi Barbash: "Psifas is a great achievement and advantage for Israel, which aspires to become a global hub of biotechnological information."
BioLight to partner with Ichilov Medical Center to develop innovative ophthalmology technologies
29.11.21
|
CTech
According to the terms of the agreement, the company will retain the primary right to license technologies developed at Ichilov